The 14 vaccines under consideration in Operation Warp Speed have not been disclosed, as far as I know; moreover, the list will be pared to 6-8 vaccines before starting clinical trials, according to this Biospace article:
ALT 4.05 - sold in afterhours. In this afternoon's earnings report they moved their Phase-1 "AdCOVID" vaccine trial from Q3 into Q4. Still like the stock for trades but no longer think it has any chance to make the cut for Operation Warp Speed.
Market Data 
Markets 
AI
